Activating mutations in PIK3CA result in the activation of the phosphoinositide 3-kinases/protein kinase B/mTOR pathway, which is commonly seen in other organs’ squamous cell carcinomas (Vivanco and Sawyers, 2002). Here, MTOR is linked to squamous cell carcinoma.